Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362545650> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4362545650 abstract "<div>Abstract<p>Contrary to other anticancer targets, topoisomerase I (TOP1) is targeted by only one chemical class of FDA-approved drugs: topotecan and irinotecan, the derivatives of the plant alkaloid, camptothecin. The indenoisoquinolines LMP400, LMP744, and LMP776 are novel noncamptothecin TOP1 inhibitors in clinical trial, which overcome the limitations of camptothecins. To further improve metabolic stability, their methoxy groups have been replaced by fluorine, as in the fluoroindenoisoquinolines NSC 781517 (LMP517), NSC 779135 (LMP135), and NSC 779134 (LMP134). We tested the induction and stability of TOP1 cleavage complexes (TOP1cc), and the induction and persistence of DNA damage measured by histone H2AX phosphorylation (γH2AX) compared with their parent compounds LMP744 and LMP776 in leukemia CCRF-CEM and colon carcinoma HCT116 cells. The fluoroindenoisoquinolines induced TOP1cc and γH2AX at nanomolar concentrations, and at higher levels than the parent indenoisoquinolines. The fluoroindenoisoquinoline LMP135 showed greater antitumor activity than topotecan in small-cell lung cancer cell H82 xenografts. It was also more potent than topotecan in the NCI-60 cancer cell line panel. Bioinformatics tools (<a href=http://discover.nci.nih.gov/cellminercdb target=_blank>http://discover.nci.nih.gov/cellminercdb</a>) were used to investigate the following: (i) the correlations of fluoroindenoisoquinolines activity with other drugs, and (ii) genomic determinants of response in the NCI-60. The activity of the fluoroindenoisoquinolines was mostly correlated with camptothecin derivatives and the parent indenoisoquinolines, consistent with TOP1 targeting. Genomic analyses and activity assays in CCRF-CEM <i>SLFN11</i>–deleted cells showed that <i>SLFN11</i> expression is a dominant determinant of response to LMP135. This study shows the potential value of the fluoroindenoisoquinolines for further development as novel anticancer agents targeting TOP1. <i>Mol Cancer Ther; 17(8); 1694–704. ©2018 AACR</i>.</p></div>" @default.
- W4362545650 created "2023-04-06" @default.
- W4362545650 creator A5021815921 @default.
- W4362545650 creator A5026197050 @default.
- W4362545650 creator A5026911605 @default.
- W4362545650 creator A5030947777 @default.
- W4362545650 creator A5036542028 @default.
- W4362545650 creator A5042114293 @default.
- W4362545650 creator A5046316270 @default.
- W4362545650 creator A5061001710 @default.
- W4362545650 creator A5061210045 @default.
- W4362545650 creator A5074228660 @default.
- W4362545650 creator A5079418869 @default.
- W4362545650 date "2023-04-03" @default.
- W4362545650 modified "2023-09-30" @default.
- W4362545650 title "Data from Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors" @default.
- W4362545650 doi "https://doi.org/10.1158/1535-7163.c.6539316" @default.
- W4362545650 hasPublicationYear "2023" @default.
- W4362545650 type Work @default.
- W4362545650 citedByCount "0" @default.
- W4362545650 crossrefType "posted-content" @default.
- W4362545650 hasAuthorship W4362545650A5021815921 @default.
- W4362545650 hasAuthorship W4362545650A5026197050 @default.
- W4362545650 hasAuthorship W4362545650A5026911605 @default.
- W4362545650 hasAuthorship W4362545650A5030947777 @default.
- W4362545650 hasAuthorship W4362545650A5036542028 @default.
- W4362545650 hasAuthorship W4362545650A5042114293 @default.
- W4362545650 hasAuthorship W4362545650A5046316270 @default.
- W4362545650 hasAuthorship W4362545650A5061001710 @default.
- W4362545650 hasAuthorship W4362545650A5061210045 @default.
- W4362545650 hasAuthorship W4362545650A5074228660 @default.
- W4362545650 hasAuthorship W4362545650A5079418869 @default.
- W4362545650 hasConcept C121608353 @default.
- W4362545650 hasConcept C143425029 @default.
- W4362545650 hasConcept C147897179 @default.
- W4362545650 hasConcept C181199279 @default.
- W4362545650 hasConcept C185592680 @default.
- W4362545650 hasConcept C2776694085 @default.
- W4362545650 hasConcept C2779682216 @default.
- W4362545650 hasConcept C2780259306 @default.
- W4362545650 hasConcept C2781209748 @default.
- W4362545650 hasConcept C502942594 @default.
- W4362545650 hasConcept C526805850 @default.
- W4362545650 hasConcept C54355233 @default.
- W4362545650 hasConcept C552990157 @default.
- W4362545650 hasConcept C55493867 @default.
- W4362545650 hasConcept C86803240 @default.
- W4362545650 hasConcept C98274493 @default.
- W4362545650 hasConceptScore W4362545650C121608353 @default.
- W4362545650 hasConceptScore W4362545650C143425029 @default.
- W4362545650 hasConceptScore W4362545650C147897179 @default.
- W4362545650 hasConceptScore W4362545650C181199279 @default.
- W4362545650 hasConceptScore W4362545650C185592680 @default.
- W4362545650 hasConceptScore W4362545650C2776694085 @default.
- W4362545650 hasConceptScore W4362545650C2779682216 @default.
- W4362545650 hasConceptScore W4362545650C2780259306 @default.
- W4362545650 hasConceptScore W4362545650C2781209748 @default.
- W4362545650 hasConceptScore W4362545650C502942594 @default.
- W4362545650 hasConceptScore W4362545650C526805850 @default.
- W4362545650 hasConceptScore W4362545650C54355233 @default.
- W4362545650 hasConceptScore W4362545650C552990157 @default.
- W4362545650 hasConceptScore W4362545650C55493867 @default.
- W4362545650 hasConceptScore W4362545650C86803240 @default.
- W4362545650 hasConceptScore W4362545650C98274493 @default.
- W4362545650 hasLocation W43625456501 @default.
- W4362545650 hasOpenAccess W4362545650 @default.
- W4362545650 hasPrimaryLocation W43625456501 @default.
- W4362545650 hasRelatedWork W121001274 @default.
- W4362545650 hasRelatedWork W1988529521 @default.
- W4362545650 hasRelatedWork W1992222388 @default.
- W4362545650 hasRelatedWork W1995556774 @default.
- W4362545650 hasRelatedWork W2021660653 @default.
- W4362545650 hasRelatedWork W2023626223 @default.
- W4362545650 hasRelatedWork W2049679426 @default.
- W4362545650 hasRelatedWork W207057374 @default.
- W4362545650 hasRelatedWork W2070716213 @default.
- W4362545650 hasRelatedWork W2155243531 @default.
- W4362545650 isParatext "false" @default.
- W4362545650 isRetracted "false" @default.
- W4362545650 workType "article" @default.